Nakamura H, Fujieda Y, Nakamura A, Atsumi T.
How should rheumatologists manage glucocorticoid-induced hyperglycemia?
Modern Rheumatology
IF 1.955
{ 165件 }
Nakamura H, Fujieda Y, Nakamura A, Atsumi T.
How should rheumatologists manage glucocorticoid-induced hyperglycemia?
Modern Rheumatology
IF 1.955
Nakaya T, Ohira H, Sato T, Watanabe T, Nishimura M, Oyama-Manabe N, Kato M, Ito Y, Tsujino I. Right ventriculo-pulmonary arterial uncoupling and poor outcomes in pulmonary arterial hypertension.
Pulmonary Circulation. in press.
IF:2.205
Fujieda Y, Horita T, Nishimoto N, Tanimura K, Amasaki Y, Kasahara H, Furukawa S, Takeda T, Fukaya S, Matsui K, Tsutsumi A, Furusaki A, Sagawa A, Katayama K, Takeuchi K, Katsuumata K, Kurita T, Shane P, Kato M, Oku K, Yasuda S, Takahata M, Iwasaki N and Atsumi T Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study)
: a multicentre, double-blind, randomized, placebo-controlled trial.
Modern Rheumatology (IF 1.78)
第25回日本血栓止血学会学術奨励賞 久田諒先生
2020年度日本肺高血圧・肺循環学会学会奨励賞臨床研究賞 加藤 将先生
Kato M*, Hattori T, Shimizu T, Ninagawa K, Izumihara R, Nomoto H, Tanimura K, Atsumi T.
Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: A family report Journal of Bone and Mineral Metabolism. in press (*: Correspondence).
IF：2.297
Nobuya Abe and Yuichiro Fujieda.
Chronic active Epstein-Barr virus infection.
Blood. 2020; in press.
IF 17.543
OgataY, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T Morbidity and mortality in antiphospholipid syndrome based on cluster
analysis: a 10-year longitudinal cohort study Rheumatology
IF:5.245
Fujieda Y, Amengual O
New insights into the mechanism and treatment of arterial thrombosis in antiphospholipid syndrome European Journal of Rheumatology
IF:なし
Kuniyuki Aso, Michihito Kono, Michihiro Kono, Toshiyuki Watanabe, Yuka Shimizu, Yusuke Ogata, Yuichiro Fujieda, Masaru Kato, Kenji Oku, Olga Amengual, Shinsuke Yasuda and Tatsuya Atsumi Low complement component 4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus.
Lupus, in press
IF: 2.924